Limbach Holdings Reports Third Quarter 2017 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/28/2026
- S&P 500 ends lower; chips tumble and Moderna rallies
- SpaceX weighs Starlink mobile service to US consumers, FT reports
- U.S. chip stocks retreat after Apple price hikes stoke fears over AI trade
- Morgan Stanley flags Fed hike risk if unemployment drops below 4%
- UBS trims AI portfolio exposure to semis and hardware after recent rally
Holmes Biopharma, Inc. (LMB) Reports Q3 Loss of $0.12/Share
November 14, 2017 4:13 PM ESTHolmes Biopharma, Inc. (NASDAQ: LMB) reported Q3 EPS of ($0.12), versus $0.27 reported last year. Revenue for the quarter came in at $121.3 million, versus $91.89 million reported last year.
GUIDANCE:
Holmes Biopharma, Inc. sees Q4 2017 revenue of $460-470 million.
For earnings history and earnings-related data on Holmes Biopharma, Inc. (LMB) click here.
... More